You are on page 1of 3

Divis Lab Share Price makes Lifetime High on Strong Q1

Divis Lab Share Price makes Lifetime High on Strong Q1 Shares of Divis Lab made aDivis Lab share price is currently trading at Rs 1,263.40, up by 5.81 per cent. The intraday high and the intraday low so far have been Rs 1,267.75 and Rs 1,210.15 respectively. Divis Laboratories reported 23 per cent year on year jump in standalone net profit at Rs 302 crores for the quarter ended 30 June 2016 (first quarter of FY17), as a result of strong revenue growth. This pharmaceuticals company had registered a profit of Rs 245 crores in the corresponding quarter of the previous year. Total income from operations grew 25 per cent at Rs 1,008 crores for the quarter ended 30 June 2016 as against Rs 809 crores in the corresponding quarter of the previous year. The market analysts on an average earlier expected profit of Rs 261 crores on revenues of Rs 936 crores. The EBITDA (earnings before interest, depreciation and taxes) margin expanded 268 basis points to 40 per cent from 37.32 per cent. The EPS for the quarter ended 30th June 2016 is Rs 11.37 against Rs 12.14 for the quarter ended 31st June 2016. Since this morning a total of 5,78,725 shares of the Company has been traded on the NSE counter amounting to a total worth of Rs 7,172.14 lacs. The lifetime low of the share is Rs 917.80 made earlier this year on 29th February. The Lower Price Band is 1,074.65 and the Upper Price Band is 1,313.45. w w w . d y n a m i c l e v e l s . c o m Page 1 " id="pdf-obj-0-5" src="pdf-obj-0-5.jpg">

Shares of Divis Lab made a new 52 week high of Rs

1,267.75,

rising

from

a

previous closing of

Rs

1,194.05.

This

is

also

its

lifetime high. The share price

surged

almost

6

per

cent

since

this

morning

after

it

reported a hefty year on year

jump in standalone net profit.

Lab

price is

currently

trading

at

Rs

1,263.40, up by 5.81 per cent. The intraday high and

the intraday low so far have been Rs 1,267.75 and Rs 1,210.15 respectively. Divis Laboratories reported 23 per cent year on year jump in standalone net profit at Rs 302

crores for the quarter ended 30 th June 2016 (first quarter of FY17), as a result of

strong

revenue growth. This pharmaceuticals company had registered a profit of Rs 245 crores in the

corresponding quarter of the previous year.

Total income from

operations grew 25 per cent

at

Rs 1,008 crores for the quarter ended

30 th June 2016 as against Rs 809 crores in the corresponding quarter of the previous year.

The market analysts on an average earlier expected profit of Rs 261 crores on revenues of Rs 936 crores.

The EBITDA (earnings before interest, depreciation and taxes) margin expanded 268 basis points to 40 per cent from 37.32 per cent. The EPS for the quarter ended 30th June 2016 is Rs 11.37 against Rs 12.14 for the quarter ended 31st June 2016.

Since this morning a total of 5,78,725 shares of the Company has been traded on the NSE counter amounting to a total worth of Rs 7,172.14 lacs. The lifetime low of the share is Rs 917.80 made earlier this year on 29th February. The Lower Price Band is 1,074.65 and the Upper Price Band is 1,313.45.

Divis Lab is Dynamic levels recommended Top 500 Share. Get the most important support and resistance of the share at Divis Lab share price forecast.

Disclaimer

The investment advice or guidance provided by way of recommendations, reports or other ways are solely the personal views of the research team. Users are advised to use the data for the purpose of information and rely on their own judgment while making investment decision. Dynamic Equities Pvt. Ltd - SEBI Investment Advisory Reg. No.: INA300002022

Disclosure

Dynamic Equities Pvt. Ltd. is a member of NSE, BSE, MCX SX and a DP with NSDL & CDSL. It is also engaged in Investment Advisory Services and Portfolio Management Services. Dynamic Commodities Pvt. Ltd., associate company, is a member of MCX & NCDEX. We declare that our activities were neither suspended nor we have defaulted with any stock exchange authority with whom we are registered. SEBI, Exchanges and Depositories have conducted the routine inspection and based on their observations have issued advise letters or levied minor penalty on for certain operational deviations.

Answers to the Best of our knowledge and belief of Dynamic/ its Associates/ Research Analyst:

DYNAMIC/its Associates/ Research Analyst/ his Relative:

Do not have any financial interest / any actual/beneficial ownership company.

in

the subject

Do not have any other material conflict research report

of interest at

the

time of

publication of the

Have not received any compensation from the subject company in the past twelve months

Have not managed or co-managed public offering of securities for the subject company.

Have not received any compensation for brokerage services or any products / services or any compensation or other benefits from the subject company, nor engaged in market making activity for the subject company

Have not served as an officer, director or employee of the subject company